Valion Bio, Inc. · NASDAQ:VBIO
3i, LP reported a 9.90% stake in Valion Bio, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 8, 2026
3i, LP reported a 9.90% stake in Valion Bio, Inc., 307,526 shares, as a passive investor on Mar 31, 2026. Filed May 8, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 307,526
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 3i, LP | 9.90% | 307,526 |
| Tumim Stone Capital LLC | 6.50% | 200,418 |
| 3i Management LLC | 9.90% | 307,526 |
| Maier Joshua Tarlow | 9.90% | 307,526 |
Source
Related
- Valion Bio, Inc.
- 3i, LP
- Valion Bio, Inc. shareholders
- Schedule 13D/A · 3i, LP · Aug 27, 2026
- Schedule 13D/A · 3i, LP · Aug 24, 2026
- Schedule 13D/A · 3i, LP · Aug 19, 2026
- Schedule 13D/A · 3i, LP · Aug 14, 2026
- Schedule 13D/A · 3i, LP · Aug 11, 2026
- Form 4 · Wolf Lisa G · Sep 24, 2026
- Schedule 13D · 3i, LP · Aug 3, 2026
- Schedule 13G · Murchinson Ltd. · Jul 17, 2026
- Form 4 · Wolf Lisa G · Jun 18, 2026
- Form 4 · Handley Michael K · May 20, 2026